Taking place on Tuesday, 10th November, the theme for this year’s event is ‘Broader horizons: growing Europe’s health partnership’.

Sure to be an interesting online event, it will focus on pediatric cancers and demonstrate how a new partnership will bring stakeholders together, synergizing with the Cancer Mission to be more inclusive in the co-creation of ideas for the program.

The free-of-charge event strives to get the widest audience possible from health and medicines R&D together. Aimed at policymakers, academics, pharmaceutical/ medical technology industries, patient representatives, regulators, and health NGOs, it’s set to discuss ideas to help develop the new partnership, avoid pitfalls and build together a world-leading collaboration.

The event will include leaders in both policymaking and science and technology, and feature a closing speech from Member of the European Parliament Maria Da Graça Carvalho; perfectly demonstrating the Innovative Medicines Initiative (IMI) public-private partnership between the EU and EFPIA – European Federation of Pharmaceutical Industries and Associations.

Follow us on LinkedIn for more industry news and events.

Additional News

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.

  • 11 September 2025

    Meet us at CPHI 2025

    This October, the global pharmaceutical community will gather in Frankfurt for CPHI 2025. Quinta-Analytica as a member of Conscio Group will be there too – visit us in the Contract Manufacturing Hall 5.1, Stand F1.

  • 8 September 2025

    Quinta-Analytica successfully passed two onsite FDA inspections

    In the first half of 2025, Quinta-Analytica underwent two onsite inspections by the U.S. Food and Drug Administration (FDA).